The intestinal microbiota influences Campylobacter jejuni colonization and extraintestinal dissemination in mice

Applied and Environmental Microbiology

Volumn 81, Issue 14, 2015, Pages 4642-4650

  O'Loughlin, Jason L ^a   Samuelson, Derrick R ^a   Braundmeier Fleming, Andrea G ^b,c   White, Bryan A ^c   Haldorson, Gary J ^a   Stone, Jennifer B ^a   Lessmann, Jeremy J ^a   Eucker, Tyson P ^a   Konkel, Michael E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; GENE ENCODING; LACTIC ACID; PATHOGENS; RECOVERY;

CAMPYLOBACTER JEJUNI; CAMPYLOBACTERS; COMPARATIVE ANALYSIS; ENTEROCOCCUS FAECALIS; FECAL PELLETS; NEXT-GENERATION SEQUENCING; OPERATIONAL TAXONOMIC UNITS; WILD-TYPE STRAIN;

MAMMALS;

ANTIBIOTICS; BACTERIAL DISEASE; BACTERIUM; COLONIZATION; COMPARATIVE STUDY; GASTROENTERITIS; GROWTH RATE; PROBIOTICS; RODENT; VIRULENCE;

CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; ENTEROCOCCUS FAECALIS; MUS; OTUS;

PROBIOTIC AGENT;

ANIMAL; BACTERIUM; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CBA MOUSE; CLASSIFICATION; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE;

ANIMALS; BACTERIA; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PROBIOTICS;

EID: 84931346846     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00281-15     Document Type: Article

References (60)

1. Blaser M. 1990. Campylobacter species, p 1649-1658. In Mandell GL, Douglas RG, Bennett JE (ed), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, NY.
2. Allos BM. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32:1201-1206. http://dx.doi.org/10.1086/319760.
3. Buzby JC, Allos BM, Roberts T. 1997. The economic burden of Campylobacter-associated Guillain-Barre syndrome. J Infect Dis 176(Suppl 2): S192-S197. http://dx.doi.org/10.1086/513785.
4. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638. http://dx.doi.org/10.1126/science.1110591.
5. Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. 2011. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 19:349-359. http://dx.doi.org/10.1016/j.tim.2011.05.006.
6. Blaut, M., Clavel, T. 2007. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137:751S-755S.
7. Lawley TD, Walker AW. 2013. Intestinal colonization resistance. Immunology 138:1-11. http://dx.doi.org/10.1111/j.1365-2567.2012.03616.x.
8. Jesudason MV, Hentges DJ, Pongpech P. 1989. Colonization of mice by Campylobacter jejuni. Infect Immun 57:2279-2282.
9. Youssef M, Corthier G, Goossens H, Tancrede C, Henry-Amar M, Andremont A. 1987. Comparative translocation of enteropathogenic Campylobacter spp. and Escherichia coli from the intestinal tract of gnotobiotic mice. Infect Immun 55:1019-1021.
10. Lee A, O'Rourke JL, Barrington PJ, Trust TJ. 1986. Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect Immun 51:536-546.
11. Savidge TC, Smith MW, James PS, Aldred P. 1991. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am J Pathol 139:177-184.
12. Shroff KE, Cebra JJ. 1995. Development of mucosal humoral immune responses in germ-free (GF) mice. Adv Exp Med Biol 371A:441-446.
13. Szeri I, Anderlik P, Banos Z, Radnai B. 1976. Decreased cellular immune response of germ-free mice. Acta Microbiol Acad Sci Hung 23:231-234.
14. Chang C, Miller JF. 2006. Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun 74:5261-5271. http://dx.doi.org/10.1128/IAI.01094-05.
15. Blaser MJ, Hopkins JA, Berka RM, Vasil ML, Wang WL. 1983. Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun 42:276-284.
16. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kuhl AA, Dasti JI, Zautner AE, Munoz M, Loddenkemper C, Gross U, Gobel UB, Heimesaat MM. 2011. Novel murine infection models provide deep insights into the "menage a trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6:e20953. http://dx.doi.org/10.1371/journal.pone.0020953.
17. Gourley CR, Konkel ME. Campylobacter jejuni molecular mechanisms and animal models of colonization and disease. In Singh SK (ed), Emerging and re-emerging human infections: genome to infectome, in press. Wiley-Blackwell, Oxford, United Kingdom.
18. Lane DJ. 1991. 16S/23S rRNA sequencing, p 115-175. In Stackebrandt E, GoodfellowM(ed), Nucleic acid techniques in bacterial systematics. John Wiley and Sons, Hoboken, NJ.
19. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 1991. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697-703.
20. Turner S, Pryer KM, Miao VP, Palmer JD. 1999. Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J Eukaryot Microbiol 46:327-338. http://dx.doi.org/10.1111/j.1550-7408.1999.tb04612.x.
21. Ruiz-Garbajosa P, Bonten MJ, Robinson DA, Top J, Nallapareddy SR, Torres C, Coque TM, Canton R, Baquero F, Murray BE, del Campo R, Willems RJ. 2006. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 44:2220-2228. http://dx.doi.org/10.1128/JCM.02596-05.
22. Dubey UK, Mistry VV. 1996. Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas. J Dairy Sci 79:1156-1163. http://dx.doi.org/10.3168/jds.S0022-0302(96)76469-X.
23. van Der Wielen PW, Biesterveld S, Notermans S, Hofstra H, Urlings BA, van Knapen F. 2000. Role of volatile fatty acids in development of the cecal microflora in broiler chickens during growth. Appl Environ Microbiol 66:2536-2540. http://dx.doi.org/10.1128/AEM.66.6.2536-2540.2000.
24. Walther-Antonio MR, Jeraldo P, Berg Miller ME, Yeoman CJ, Nelson KE, Wilson BA, White BA, Chia N, Creedon DJ. 2014. Pregnancy's stronghold on the vaginal microbiome. PLoS One 9:e98514. http://dx.doi.org/10.1371/journal.pone.0098514.
25. Schachtschneider KM, Yeoman CJ, Isaacson RE, White BA, Schook LB, Pieters M. 2013. Modulation of systemic immune responses through commensal gastrointestinal microbiota. PLoS One 8:e53969. http://dx.doi.org/10.1371/journal.pone.0053969.
26. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335-336. http://dx.doi.org/10.1038/nmeth.f.303.
27. Reingold L, Rahal K, Schmiedlin-Ren P, Rittershaus AC, Bender D, Owens SR, Adler J, Zimmermann EM. 2013. Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: effect of genetic background. Inflamm Bowel Dis 19:1238-1244. http://dx.doi.org/10.1097/MIB.0b013e31828132b4.
28. Lopez CA, Winter SE, Rivera-Chavez F, Xavier MN, Poon V, Nuccio SP, Tsolis RM, Baumler AJ. 2012. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. mBio 3(3):e00143-12. http://dx.doi.org/10.1128/mBio.00143-12.
29. Neal-McKinney JM, Konkel ME. 2012. The Campylobacter jejuni CiaC virulence protein is secreted from the flagellum and delivered to the cytosol of host cells. Front Cell Infect Microbiol 2:31. doihttp://dx.doi.org/10.3389/fcimb.2012.00031.
30. Samuelson DR, Eucker TP, Bell JA, Dybas L, Mansfield LS, Konkel ME. 2013. The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease. Cell Commun Signal 11:79. http://dx.doi.org/10.1186/1478-811X-11-79.
31. Neal-McKinney JM, Lu X, Duong T, Larson CL, Call DR, Shah DH, Konkel ME. 2012. Production of organic acids by probiotic lactobacilli can be used to reduce pathogen load in poultry. PLoS One 7:e43928. http://dx.doi.org/10.1371/journal.pone.0043928.
32. Zamakhchari M, Wei G, Dewhirst F, Lee J, Schuppan D, Oppenheim FG, Helmerhorst EJ. 2011. Identification of Rothia bacteria as glutendegrading natural colonizers of the upper gastro-intestinal tract. PLoS One 6:e24455. http://dx.doi.org/10.1371/journal.pone.0024455.
33. Xu J, Gordon JI. 2003. Honor thy symbionts. Proc Natl Acad Sci USA 100:10452-10459. http://dx.doi.org/10.1073/pnas.1734063100.
34. Thijm HA, van der Waaij D. 1979. The effect of three frequently applied antibiotics on the colonization resistance of the digestive tract of mice. J Hyg 82:397-405. http://dx.doi.org/10.1017/S0022172400053924.
35. Kalliomaki MA, Walker WA. 2005. Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium. Gastroenterol Clin North Am 34:383-399, vii. http://dx.doi.org/10.1016/j.gtc.2005.05.007.
36. Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A, Hinton JC, Van Immerseel F. 2006. Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 72:946-949. http://dx.doi.org/10.1128/AEM.72.1.946-949.2006.
37. Cherrington CA, Hinton M, Pearson GR, Chopra I. 1991. Short-chain organic acids at pH 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol 70:161-165. http://dx.doi.org/10.1111/j.1365-2672.1991.tb04442.x.
38. Marteyn B, Scorza FB, Sansonetti PJ, Tang C. 2011. Breathing life into pathogens: the influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract. Cell Microbiol 13:171-176. http://dx.doi.org/10.1111/j.1462-5822.2010.01549.x.
39. Diehl GE, Longman RS, Zhang JX, Breart B, Galan C, Cuesta A, Schwab SR, Littman DR. 2013. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 494:116-120. http://dx.doi.org/10.1038/nature11809.
40. Buffie CG, Pamer EG. 2013. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790-801. http://dx.doi.org/10.1038/nri3535.
41. Dicksved J, Ellstrom P, Engstrand L, Rautelin H. 2014. Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. mBio 5(5):e01212-14. doihttp://dx.doi.org/10.1128/mBio.01212-14.
42. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71:2839-2858. http://dx.doi.org/10.1128/IAI.71.5.2839-2858.2003.
43. Stahl M, Ries J, Vermeulen J, Yang H, Sham HP, Crowley SM, Badayeva Y, Turvey SE, Gaynor EC, Li X, Vallance BA. 2014. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key proinflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog 10:e1004264. http://dx.doi.org/10.1371/journal.ppat.1004264.
44. Stecher B, Barthel M, Schlumberger MC, Haberli L, Rabsch W, Kremer M, Hardt WD. 2008. Motility allows S. Typhimurium to benefit from the mucosal defence. Cell Microbiol 10:1166-1180. doihttp://dx.doi.org/10.1111/j.1462-5822.2008.01118.x.
45. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070-11075. http://dx.doi.org/10.1073/pnas.0504978102.
46. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Dore J. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189. http://dx.doi.org/10.1002/ibd.20903.
47. Hansen J, Gulati A, Sartor RB. 2010. The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol 26:564-571. http://dx.doi.org/10.1097/MOG.0b013e32833f1195.
48. Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM. 2012. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 7:e35988. http://dx.doi.org/10.1371/journal.pone.0035988.
49. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341. http://dx.doi.org/10.1126/science.1198469.
50. Holzapfel, WH, Haberer P, Geisen R, Bjorkroth J, Schillinger, U. 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73:365S-373S.
51. Giraffa G, Sisto F. 1997. Susceptibility to vancomycin of enterococci isolated from dairy products. Lett Appl Microbiol 25:335-338. http://dx.doi.org/10.1046/j.1472-765X.1997.00241.x.
52. Christoffersen TE, Jensen H, Kleiveland CR, Dorum G, Jacobsen M, Lea T. 2012. In vitro comparison of commensal, probiotic and pathogenic strains of Enterococcus faecalis. Br J Nutr 108:2043-2053. http://dx.doi.org/10.1017/S0007114512000220.
53. Robyn J, Rasschaert G, Hermans D, Pasmans F, Heyndrickx M. 2013. In vivo broiler experiments to assess anti-Campylobacter jejuni activity of a live Enterococcus faecalis strain. Poult Sci 92:265-271. http://dx.doi.org/10.3382/ps.2012-02712.
54. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375. http://dx.doi.org/10.1128/IAI.01520-08.
55. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280. http://dx.doi.org/10.1371/journal.pbio.0060280.
56. Robinson CJ, Bohannan BJ, Young VB. 2010. From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev 74:453-476. http://dx.doi.org/10.1128/MMBR.00014-10.
57. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. 2012. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 80:3786-3794. http://dx.doi.org/10.1128/IAI.00647-12.
58. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8:e1002995. http://dx.doi.org/10.1371/journal.ppat.1002995.
59. Britton RA, Young VB. 2014. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146:1547-1553. http://dx.doi.org/10.1053/j.gastro.2014.01.059.
60. -/- mice via Toll-like receptor-2 and-4 signaling. PLoS One 7:e40761. http://dx.doi.org/10.1371/journal.pone.0040761.